Enrichment analysis of 50 cancer hallmarks and 132 immune signaling modules showed that CSF-1, MYC, TGF-β, JAK/STAT3, IFN-α, and the other 29 signaling pathways were enriched in C2 versus C1 subtype (Figure S5, P < 0.05). This evidence concerns the gene CSF1 and cancer.